Homoeopathic ointment for treatment of hemorrhoids, dermatitis and rhinitis

FIELD: medicine, in particular homoeopathic ointment for treatment of hemorrhoids, dermatitis and rhinitis.

SUBSTANCE: claimed ointment includes Calendula D 1, Hamamelis D 1, Aesculus D 1, and menthol as active ingredients and zinc oxide and vaseline as ointment base in specific ratio. Ointment of present invention makes it possible to improve microcirculation and cell respiration in tissues, to reduce venous engorgement, to increase immunity, to stimulate regeneration processes.

EFFECT: ointment for treatment of hemorrhoids, dermatitis and rhinitis of improved effect.

1 tbl

 

The invention relates to the creation of a homeopathic ointment for the treatment of hemorrhoids, dermatitis and rhinitis.

Known composition, representing an oily yellow liquid with a brownish or greenish with a specific smell. Contains sesquiterpene derivatives, glycosides, carotenoids, menthol, cineole, algaenan, anethole, various micro - and macronutrients for the treatment of dermatitis, hemorrhoids, rhinitis, sinusitis, etc. (RF patent 2106875 from 20.03.1998).

The present invention is the extension of homeopathic remedies for the treatment of hemorrhoids, dermatitis and rhinitis with a wide range of pharmacological effects.

This object is achieved in that the proposed ointment for the treatment of hemorrhoids, dermatitis and rhinitis, including Calendula D1, Hamamelis D1, Aesculus D1, menthol and as the basis of a zinc oxide and petrolatum, taken in the following ratio, wt.%

Calendula D1 1,7-1,8

Hamamelis D1 1,7-1,8

Aesculus D1 1,7-1,8

Zinc oxide of 9.3 to 9.5

Menthol 0,63-0,65

Vaseline else

Homeopathic product called “OINTMENT FLEMING”.

OINTMENT FLEMING is an ointment, white with a yellowish sheen color with a characteristic odor of menthol. The drug is an original composition based on homeopathic medicinal products of plant and mineral origin.

Composition 10 g ointment:

Calendula D1 (Marigold drug) 1,7-1,8

Hamamelis D1 (Hamamelis virginiana) 1,7-1,8

Aesculus D1 (Chestnut) 1,7-1,8

Zinci oxydum (zinc Oxide) of 9.3 to 9.5

Mentolum (Menthol) 0,63-0,65

Vaselinum (Vaseline) to 100 g

The invention is illustrated by the following example.

Homeopathic dilution: Calendula D1, Witch hazel D1, Esculus D1 is obtained from plant materials by method 3A according to homeopathic technology of preparation of medicines.

In the tank mix homeopathic dilution: Calendula D1, Witch hazel D1, Esculus D1. The resulting volume of homeopathic dilutions dissolve the menthol. Zinc oxide in a number of techniques grind about an equal amount of petroleum jelly.

In the installation for the preparation of ointments put the melted vaseline, mix it with the calculated amount of zinc oxide and 2-3 reception add a mixture of menthol and dilutions: Calendula D1, Witch hazel D1, Esculus D1. Then include installing and thoroughly mix to obtain a homogeneous ointment, after which the ointment is Packed with 15 or 25 g vials polymer with straining lid with opening control.

Store at temperature not exceeding 25°protected from light, out of reach of children. The shelf life is 2 years.

Indications for use:

External hemorrhoids, uncomplicated forms

Vasomotor rhinitis

Allergic dermatitis.

SP is the way of application and dose

When gammarae ointment apply 1-3 times daily with a cotton swab. Treatment 5-7 days. The recurrence rate after consultation with a physician.

When rhinitis ointment to lubricate the mucous membranes of the nose or turunda with ointment to lay in the nose for 5-7 minutes 2-3 times a day. The course of treatment is 7-10 days.

Contraindications

Hypersensitivity to the drug components.

Allergic dermatitis ointment to apply on the painful areas of skin 2 times a day. Treatment 10-14 days.

Side effect

Not found.

Evaluation of the effectiveness of the drug was carried out on the basis of the Homeopathic hospital №82 St. Petersburg.

In assessing the effectiveness and tolerability of the drug “OINTMENT FLEMING” was considered as subjective feelings of the patient and objective indicators of monitoring of a physician taking into account the data required, in the opinion of the physician, and laboratory studies.

Criteria of an estimation of results of treatment:

“Good” - on the background of therapy has been a clear positive trend in the patient's condition and laboratory data.

“Satisfactory” clinical symptoms are less pronounced, the patient's condition and laboratory data improved.

“Lack of effect”.

Were summarized and analyzed the histories of 492 patients diagnosed with vasomotor rhinitis.

atrast patients ranged from 18-65 years. Of them women - 296, men - 196.

Patients were referred to a doctor with complaints of nasal obstruction, decreased sense of smell, nasal discharge, headache, slight fever, chills, dryness in nose, sneezing, irritation of the nose, bleeding from the nose.

Of all complaints to control were the most frequent symptoms: nasal congestion - 475 patients, mucous discharge in the nasal passages and nasopharynx - 490 patients, edema and cyanosis of the lower turbinates - 414 patients, decreased sense of smell - 414 patients.

All patients in treatment was prescribed OINTMENT FLEMING 2-3 times a day.

On the second day of applying ointment 30% of patients underwent nasal congestion. On the third day began to disappear mucous discharge from the nose in 5% of patients, decreased edema 1% of patients, there was a smell in 3% of patients. On the fourth day completely stopped complaints stuffy nose, and on the sixth day of mucus, on the eighth day the smell was restored in all patients, on the tenth day mentioned the disappearance of edema and cyanosis, nasal Concha in all patients.

Thus, the duration of drug treatment was 6-10 days.

The lack of side effects of the drug OINTMENT FLEMING.

Assessment of drug efficacy in allergic dermatitis

the yli summarized and analyzed the histories of 78 patients. The age of patients ranged from 18 to 65 years, women - 47, male - 31. Patients were turned to the doctor complaining of itching and flaking of the skin, rashes and cracks on the skin, swelling of the tissues, formation of vesicular vesicles, crusts and after brushing. Of all complaints to control were the most frequent symptoms: itching of the skin - 78 patients, skin rash - 78 patients, cracks in the skin - 60 patients, peeling skin - 51 patient.

All patients in treatment was prescribed OINTMENT FLEMING 2 times a day.

On the second day of applying ointments patients noted a decrease itching and swelling, reduction of cracks on the skin. When you visit the doctor on day 5 of the application of the ointment itching was observed in 10% of patients, rash in 27%, skin cracks at 25%, peeling skin in 23% of patients. To a 14-day application of ointments only 5% of the patients showed peeling of the skin.

Thus, the duration of treatment was 10 to 14 days.

They noted the absence of a side effect of the drug OINTMENT FLEMING.

Evaluation of the effectiveness of the drug in the treatment of hemorrhoids

Were summarized 270 histories of patients using homeopathic medicine OINTMENT FLEMING about hemorrhoids.

Among the patients were mostly women 61,5%. The distribution of patients by age shows that patients aged 20-50 years SOS is awile 44,4%, 51-70 years - 43.7 per cent over the age of 70 years is 11.9%.

In the initial examination, all 270 patients were diagnosed with hemorrhoids. Characteristic symptoms in varying combinations were observed in all patients.

In the initial examination at the 96.3% of patients had pain, 71,5% had dense nodes, 28.1 per cent fissures, 25.5% of violations of the chair, 16.6% of the blood in fecal matter, 78,9% - discomfort after a bowel movement.

For the treatment of hemorrhoids patients ointment was applied 1-3 times a day using a cotton swab. Treatment 5-7 days.

When re-examination of patients after 5-6 days the overwhelming number of patients (92%) acute effects were quiet.

So pain is preserved only in 7.8% of patients, sites were softened down when pressed, swollen only when natureway in 5.9% of patients, blood, fecal matter was determined only in 0.7% of patients.

When using the drug OINTMENT FLEMING adverse and allergic reactions were not observed in any case.

therapeutic effect how good was seen in 92% of patients, satisfactory in 7%, and poor in 1% of patients.

OINTMENT FLEMING used in treatment of vasomotor rhinitis. When this ointment nasal breathing easier, reduces swelling and cyanosis of the nasal Concha, restores sense of smell helps eliminate mucus within 6-10 days.

<> The efficacy of 89%.

In the treatment of allergic dermatitis application of OINTMENTS FLEMING relieves itching, helps cleanse skin and the healing of fractures.

The effectiveness of the drug - 79%.

When treating hemorrhoids ointment helps to relieve pain, reduce inflammation, eliminate bleeding.

The effectiveness of the drug is 92%.

In complex homeopathic medicine OINTMENT FLEMING use homeopathic substance Calendula, Witch hazel, Escalus in low decimal potencies that have organotropic action in acute conditions.

According to clinical observations and literature data OINTMENT FLEMING has antiexudate, antiproliferative, dried and antipruritic actions, possesses analgesic, hemostatic, antibacterial effects, improves microcirculation and cellular respiration in the tissues, reduces venous congestion, improves the immune system, stimulates regeneration processes.

Ointment for the treatment of hemorrhoids, dermatitis and rhinitis, including active substance and ointment base, characterized in that it as active substances it contains Calendula D1, Hamamelis D1, Aesculus D1, menthol and as ointment bases - zinc oxide and petrolatum in the following ratio, wt.%

Calendula D1 1,7-1,8

Hamamelis D1 1,7-1,8

Aesculus D1 1,7-1,8

Zinc oxide of 9.3 to 9.5

Menthol 0,63-0,65

Vaseline Else



 

Same patents:

FIELD: skin diseases.

SUBSTANCE: invention provides vaccine containing 1 to 4 vaccinal strains of dermatophites, which can be used for immunoprophylactice and treatment of dermatophitoses. Invention also provides a method for preparation of such vaccine.

EFFECT: enabled skin application of vaccine thereby reducing risk of appearance of anaphylactic reactions.

22 cl, 9 ex

FIELD: medicine, dermatology.

SUBSTANCE: it is suggested to apply quingamin in combination with prednisolone. The latter should be prescribed at its average daily dosages, and quingamin daily dosage should be increased for 120-130 mg every 9-11 d beginning from 120-130 mg to reach 450-500 mg/d. Moreover, course dosage of quingamin corresponds to 15-18 mg. The method decreases toxic reactions to quingamin introduction.

EFFECT: higher efficiency of therapy.

1 cl, 1 ex

FIELD: medicine, dermatology, cosmetology.

SUBSTANCE: the present innovation deals with treating inguinal diseases. For this purpose at the first stage one should removed detached or hypertrophied layers of inguinal horn cells due to layer-by-layer polishing with drill's diamond head to detect pathological defects in inguinal layers or under the nail or their removal or straightening. Then comes interval during 3-7 d. At the second stage one should remove redetached layers followed by another interval for 3-7 d. Polishing stages of detached layers should be carried out till restoration of nail matrix growth towards its free edge, moreover, it is necessary to smooth and polish inguinal surface with manicure filing. Moreover, one should apply dimexide lotions during therapy. The innovation leads to quick and valuable inguinal restoration due to keeping the bond of nail matrix, nail bed, and subunguinal matrix at carrying out restorative stages of inguinal growth.

EFFECT: higher efficiency of restoration.

3 ex, 1 tbl

FIELD: medicine, dermatology.

SUBSTANCE: one should apply an applicator onto affected parts of skin that contains 5-aminolevulinic acid at concentration of 5-20%. After keeping and removing the applicator it is necessary to irradiate with light at wave length being 630 ± 10 nm and energy density of 10-1200 J/sq. cm. Control should be carried out due to evaluating the concentration of photosensitizer at affected parts of skin due to fixing fluorescence ranges at all basic stages of photodynamic therapy. The method enables to adjust skin relief and achieve scars' whitening and their regression.

EFFECT: higher efficiency of therapy and control.

6 cl, 2 dwg, 3 ex

FIELD: pharmaceutics.

SUBSTANCE: the innovation deals with manufacturing remedies to prevent wound suppuration based upon polymeric matrix and antimicrobial substance due to mixing components in solution, forming the film to obtain a powder-like medicinal form by providing the safety of antimicrobial activity of medicinal preparation. The obtained remedy is completely biodestructed in the body and requires no repeated operation on its removal after the end of tissue regeneration processes.

EFFECT: higher efficiency of manufacturing.

1 cl, 3 ex, 1 tbl

FIELD: medicine.

SUBSTANCE: the present innovation deals with preparing ointments to be applied at treating both surface and deeply penetrating cutaneous burns and other skin diseases, as well. Composition of the suggested ointment includes, weight%: 45…67% food sunflower oil, 15…37% food olive oil, 1…2% Calendulae officinalis extract, 0.8…1.8% labdanum, 2.5…8% colophony, 6.5…11.5% white bee wax, 0.7…1.8% the main bismuth gallate and 0.7…1.8% camphor. The suggested ointment is highly efficient for rapid and successful treatment of burns III and IV degree. It should be also applied for treating shin's ulcer and, also, in gynecology - for treating inflammation of uterine cervix.

EFFECT: higher efficiency of therapy.

4 ex

FIELD: medicine, cosmetology.

SUBSTANCE: one should detect the scope of eruption, the availability of psychoemotional disorders, then, by taking into consideration patient's sex it is necessary to calculate Monakhov's therapeutic acne index (MTAI) by a certain formula to prescribe therapy by taking into account the index obtained. The present innovation provides individual approach to prescribing anti-acne therapy that, in its turn, enables to shorten the terms of disease, decrease the number of jatrogenic complications and prolong remission period.

EFFECT: higher efficiency of anti-acne therapy.

13 ex, 4 tbl

FIELD: pharmaceutics.

SUBSTANCE: the suggested composition has got viscosity being below of about 15000 cP and pH being approximately 3.0-9.0 for treating human skin diseases. He suggested composition consists of (a) therapeutically efficient quantity of, at least, one compound being useful in treating the above-mentioned disease; (b) pharmaceutically acceptable, partially bound polymer of polyacrylic acid being compatible with the compound; (c) not obligatory, a solvent being mixed with water, (d) not obligatory, a conserving agent, (e) not obligatory, a component of butyric phase and acceptable surface-active substance, and (f) water. The suggested composition is useful to treat inflammatory skin disease, acne or acne erythematosa. The composition of low viscosity has got its advantage in the fact that it is applied more accurately when in contact with a container that doses the composition in the form of drops.

EFFECT: higher efficiency of application.

23 cl, 15 ex, 19 tbl

FIELD: medicine.

SUBSTANCE: the present innovation deals with treating different wounds. The suggested perfluorocarbon emulsion is being used as the medium in case of ultrasound treatment of wounds. Moreover, the enhancement of reparative processes is observed in the wound along with accelerated wound healing due to development of perfluorophages in area of inflammatory process and to higher gas saturation of perfluorocarbon emulsion against other media applied before. The emulsion under the action of low-frequency ultrasound obtains other properties (increased specific weight, increased fluidity, higher wettability of purified surface, the presence of abrasive properties) necessary for achieving technical result. All these measures, thus, enhance reparative processes in the wound because low-frequency ultrasound raise to a higher power the action of perfluorocarbon emulsion both regarding ultrasound purification and its curative action upon wound.

EFFECT: higher efficiency.

5 dwg, 1 ex

FIELD: medicine, dermatology.

SUBSTANCE: the suggested therapeutic method includes complex therapy with "Affinoleukin" being its one component. Depending upon the severity of disease flow, necessary dosages and the mode for preparation injection have been elaborated. The method provides efficient treatment due to competitive interaction of "Affinoleukin" with homologous antigens participating in pathogenesis of disease development that leads to interruption of disease symptoms being resistant to other kinds of therapy.

EFFECT: more prolonged period of remission.

4 cl, 3 ex, 2 tbl

FIELD: pharmaceutical industry.

SUBSTANCE: agent, in particular, contains N-(2-ethylsulfonylamino-5-trifluoromethylpyrid-3-yl-cycloxancarboxamide or its salt.

EFFECT: reduced side action and increased therapeutical efficiency.

2 tbl

FIELD: pharmaceutics.

SUBSTANCE: the present innovation deals with preventing and treating oxygen deficiency due to applying birch bark extract to increase body resistance to oxygen deficiency. Moreover, the above-mentioned extract could be applied at treating diseases accompanying oxygen deficiency. Birch bark extract provides more efficient prophylaxis and therapy of oxygen deficiency.

EFFECT: higher efficiency of application.

4 cl, 2 ex, 2 tbl

FIELD: organic chemistry, medicine.

SUBSTANCE: invention relates to new 2-aminopyridine derivatives of formula I , wherein R1 is cyano, carboxyl or carbamoyl; R2 is hydrogen, hydroxyl, C1-C6-alkoxy or phenyl; R3 and R4 are aromatic hydrocarbon such as phenyl or naphthyl, 5-14-membered 5-14-membered optionally substituted aromatic group, excepted cases, when (1) R1 is cyano, R2 is hydrogen, and R3 and R4 are simultaneously phenyl;(2) R1 is cyano, R2 is hydrogen, R3 is 4-pyridyl, and R4 is 1-pyridyl; (3) R1 is cyano, R2 is 4-methylphenyl, and R3 and R4 are simultaneously phenyl;(4) R1 is cyano, R2, R3 and R4 are simultaneously phenyl, or salts thereof. Derivatives of present invention have adenosine receptor antagonist activity and are useful in medicine for treatment of irritable bowel syndrome, constipation, and defecation stimulation.

EFFECT: 2-aminopyridine derivatives as adenosine receptor antagonists useful in medicine.

34 cl, 2 tbl, 179 ex

FIELD: biochemistry, medicine.

SUBSTANCE: invention relates to phenylalanine derivatives of formula I , wherein X1 and X2 are halogen; Q is CH2 or -(CH2)-; Y is C1-C6-alkyl; CO2R is carboxylic group which may be transetherified; or pharmaceutically acceptable salts thereof. Pharmaceutical composition is disclosed having inhibition activity against α4-integrine mediated cell adhesion. Said composition includes therapeutically effective amount of claimed derivative or pharmaceutically acceptable salt thereof in mixture with pharmaceutically acceptable carrier or diluent. Derivatives of present invention or pharmaceutically acceptable salt thereof are useful as active therapeutic agent inhibiting α4-integrine mediated cell adhesion. Also disclosed are application of phenylalanine derivatives of formula I or pharmaceutically acceptable salts thereof to produce drug for treatment of diseases associated with α4-integrine mediated cell adhesion. Method for treatment or prophylaxis diseases associated with α4-integrine mediated cell adhesion includes administrating to patient effective amount of phenylalanine derivatives of formula I or pharmaceutically acceptable salt thereof. Further methods (variants) for production of target derivatives are disclosed.

EFFECT: α4-integrine inhibiting phenylalanine derivatives.

20 cl, 42 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: the suggested pharmaceutical composition includes formoterol and its pharmaceutically acceptable salt and flucticason propionate at their weight ratio being, correspondingly, 1 : 5 to 1 : 50. Combined application of flucticason propionate and formoterol fumarate provides synergistic therapeutic action that enables to decrease the dosage of flucticason propionate for achieving concrete antiphlogistic action that leads to possible unfavorable side effects.

EFFECT: higher efficiency of application.

10 cl, 216 ex

FIELD: organic chemistry, biochemistry, medicine, pharmacy.

SUBSTANCE: invention relates to new aminobenzophenones of the formula (I):

or their pharmaceutically acceptable salts. These compounds elicit properties of inhibitors of cytokines secretion, in particular, 1β-interleukin (IL-1β) and tumor necrosis α-factor (TNF-α) and to secretion of polymorphonuclear superoxide that are useful for treatment of inflammatory diseases, for example, skin diseases, such as psoriasis, atopic dermatitis. In the formula (I) R1 is taken among the group consisting of halogen atom, hydroxy-, mercapto-group, trifluoromethyl, amino-group, (C1-C3)-alkyl, (C2-C3)-olefinic group, (C1-C3)-alkoxy-, (C1-C3)-alkylthio-, (C1-C6)-alkylamino-group, (C1-C3)-alkoxycarbonyl, cyano-group, carbamoyl, phenyl or nitro-group under condition that when R1 means a single substitute then it at ortho-position, and when R1 means more one substitute then at least one substitute of R1 is at ortho-position; R2 means one substitute at ortho-position being indicated substitute is taken among the group consisting of (C1-C3)-alkyl, (C1-C3)-alkoxy-group; R3 means hydrogen, halogen atom, hydroxy-, mercapto-group, trifluoromethyl, amino-group, (C1-C3)-alkyl, (C2-C3)-olefinic group, (C1-C3)-alkoxy-, (C1-C3)-alkylthio-, (C1-C6)-alkylamino-group, (C1-C3)-alkoxycarbonyl, phenyl, cyano-, carboxy-group or carbamoyl; R4 means hydrogen atom or (C1-C3)-alkyl; Q means a bond or -SO2-; Y means (C1-C15)-alkyl, (C3-C10)-carbocyclic group or phenyl being each of them can be substituted optionally with one or some similar or different substitutes designated by the formula R5; R5 means halogen atom, (C1-C4)-alkyl, amino-, (C1-C3)-alkoxy-group, (C1-C3)-alkoxycarbonyl or -COOH; X means oxygen or sulfur atom. Also, invention relates to a pharmaceutical composition and to a method for treatment and/or prophylaxis of inflammatory diseases.

EFFECT: valuable medicinal properties of compounds and composition.

9 cl, 2 sch, 2 tbl, 29 ex

FIELD: pharmaceutical industry.

SUBSTANCE: antitussive preparation comprises thermopsis grass in the form of powder or dry extract, sodium hydrocarbonate, pharmaceutically acceptable granulating agent, pharmaceutically acceptable gliding substance, and, additionally, dry or thick liquorice extract, sodium benzoate, ammonium chloride, and anise oil.

EFFECT: improved reliability during tableting and storage.

3 cl, 1 tbl, 16 ex

FIELD: medicine, parapharmaceutical industry.

SUBSTANCE: invention relates to industry manufacturing preparations for curative and prophylactic aims and can be used as a curative and prophylactic, bactericidal, antiviral, anti-inflammatory, analgetic agent promoting to regulation of respiratory organs. The preparation eliciting anti-inflammatory and antibacterial properties comprises dry concentrate of propolis alcoholic tincture, ascorbic acid, fruit essence dry concentrate, citric acid, calcium stearate and sugar taken in the definite ratio of components. The preparation expands assortment of medicinal agents used for treatment of acute and chronic diseases of respiratory organs and represents alternative variant for cases with individual intolerance of some components.

EFFECT: valuable medicinal properties of preparation.

1 tbl

FIELD: medicine, pulmonology.

SUBSTANCE: one should apply lycopid to study initial level of mature T-cells (CD3+) in % and solve following discriminant equation: D = 0.840 · (CD3+), and at D value being above 29.24 one should predict positive curative effect as a result of lycopid application, and at D value being below 29.24 on should predict no positive curative effect.

EFFECT: higher efficiency of lycopid-including therapy.

2 ex

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to new derivatives of indolylpiperidine of the formula (I): wherein A1 means (C1-C7)-alkylene, (C1-C7)-alkyleneoxy-, (C1-C7)-alkylenethio-, (C1-C7)-alkanoyl, hydroxy-(C1-C7)-alkylene; A2 means a single bond, (C1-C7)-alkylene, (C2-C5)-alkenylene; W means a single bond, phenylene, furanylene that is unsubstituted or substituted with one or more halogen atoms, (C1-C7)-alkoxy- and/or alkyl groups; R1 means hydrogen atom (H), (C1-C7)-alkyl, (C2-C7)-alkenyl, (C2-C7)-alkynyl, (C2-C5)-alkoxyalkyl, (C3-C7)-alkenyloxyalkyl, (C3-C7)-alkynyloxyalkyl, (C3-C7)-alkoxyalkoxyalkyl, phenyl-(C1-C7)-alkyl wherein phenyl is unsubstituted or substituted with one or more halogen atoms, (C1-C7)-alkyl, (C1-C7)-alkoxy- or arylalkoxy- (preferably with phenylalkoxy-) groups, or means (C3-C10)-cycloalkyl-(C1-C7)-alkyl wherein cycloalkyl is unsubstituted or substituted with one or more halogen atoms, (C1-C7)-alkyl, (C1-C7)-alkoxy-groups; R2 means hydrogen atom (H), halogen atom, (C1-C7)-alkyl, (C1-C7)-alkoxy-; R3 means carboxyl, tetrazolyl, and to their pharmaceutically acceptable salts. Compounds of the formula (I) elicit antihistaminic and anti-allergic activity that allows their using in composition used for treatment of allergic diseases including bronchial asthma, rhinitis, conjunctivitis, dermatitis and nettle rash. Also, invention describes methods for preparing compounds of the formula (I).

EFFECT: valuable medicinal properties of compounds.

15 cl, 2 sch, 3 tbl, 162 ex

FIELD: medicine.

SUBSTANCE: the present innovation deals with preparing ointments to be applied at treating both surface and deeply penetrating cutaneous burns and other skin diseases, as well. Composition of the suggested ointment includes, weight%: 45…67% food sunflower oil, 15…37% food olive oil, 1…2% Calendulae officinalis extract, 0.8…1.8% labdanum, 2.5…8% colophony, 6.5…11.5% white bee wax, 0.7…1.8% the main bismuth gallate and 0.7…1.8% camphor. The suggested ointment is highly efficient for rapid and successful treatment of burns III and IV degree. It should be also applied for treating shin's ulcer and, also, in gynecology - for treating inflammation of uterine cervix.

EFFECT: higher efficiency of therapy.

4 ex

Up!